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1 Introduction
This is our ﬁrst review for RSC Specialist Periodical Reports on the ﬁeld of
NMR of carbohydrates, lipids and membranes, which from 1995 until now
has been written by Dr. Hounsell. Our contribution covers the literature
published between June 2009 and May 2010. The number of the papers
devoted to the structure and interactions of these compounds is quite large
although we included in our review only those papers which were accessible,
peer-reviewed and printed. The reviewed material has been arranged in
sections devoted to the structure of the compounds being discussed and
interactions between them. It contains two distinct main parts. In the ﬁrst
part the literature on carbohydrates and on their non-covalent interactions
to peptides/proteins and to synthetic/natural products has been outlined. In
this part also the data on glycopeptides has been included. In the second
part the papers devoted to proteins/peptides – lipids interactions in the
membranes, lipidated proteins, lipoproteins, lipids and membranes, and
glycolipids have been collected. A special section has been devoted to
metabonomic studies and ﬁnally, in the last one the new NMR methods




Numerous authors have utilized NMR for elucidation of the structure of
complex oligo- and polysaccharides derived from various organisms. Since
these saccharides are of crucial importance, e.g. for cellular biology,
pharmaceutical therapy and industrial applications, a survey of this litera-
ture is presented below. The eukaryotic and prokaryotic saccharides are
discussed separately.
2.1.1 Eukaryotic polysaccharide structure. Abronina et al.1 have utilized
2D NOESY to establish the stereochemistry at C-1 of the newly developed
anomeric O-benzoylated a- and b-D-mannopyranosyl azides. The solid
state 13C NMR method have been used by Mossine et al.2 to evidence that
D-fructose-N-allylaniline crystallizes exclusively in the b-pyranose form.
Tafazzoli and Giasi3 have presented empirical formula linking anomeric
carbon chemical shift with the glycosidic bond dihedral angles useful in
conformational analysis of cyclodextrins. 1D 1H or 13C NMR has been
employed to evaluate the degree of deacetylation of chitosan (marine
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of polymerization of highly ordered cellulose II by cellodextrin phosphor-
ylase by Hiraishi et al.;5 to compare diﬀerent synthetic routes for starch
acetates by Volkert et al.;6 to elucidate the eﬀect of the reaction parameters
on the structure of octenyl succinic anhydride–modiﬁed hyaluronic acid
polysaccharide by Eenschooten et al.7
A similar method has been used by Shin et al.8 to determine the abundance
of a-1,6-glucisidic linkages in starch-related a-glucans (determinant of
glucose release by lytic enzymes) and by Kimmel et al.9 to analyze the
formation of glycosidic linkages of N-unsubstituted 4-hydroxyquinolin-2-
(1H)-ones (potential pharmaceutics).
1D and 2D NMR homo- and/or heteronuclear spectra have been used by
Guerrini et al.10,11 to detect and quantify sulfated polysaccharides contamin-
ating heparin10 and to detect various components of sidestream heparin,11
and by Deng et al.12 to elaborate the procedure for structural characterization
of rhamnogalacturonans, plant cell wall heteropolysaccharides.
The conformational features of hyaluronic acid have been investigated
by Gargiulo et al.13 in isotropic and anisotropic conditions using standard
2D homo- and heteronuclear experiments.
Homo- and/or heteronuclear NMR spectra, e.g. COSY, ROESY, HSQC,
HMQC-TOCSY, HMBC, PANSY, NOESY-HSQC TILT, have been used
for determination of the linkage and/or structure of the polysaccharides
isolated from various tissues of eukaryotic organisms (see Table 1).
Guilherme et al.85 have used 1D NMR to estimate the structure of a
vinyl-functionalized pectin and solid-state 13C CP-MAS NMR to elucidate
the formation of hydrogels. The crystallinity of cellulose in plant organs has
been analyzed by Takahashi et al.86 using 13C CP-MAS NMR. Manni
et al.87 have used 13C NMRwith CP-MAS technique to estimate the structure
of chitin prepared by the enzymatic deproteinization of shrimp wastes.
Rudd et al.88 have presented a review on application of high resolution
NMR to the analysis of glycosaminoglycans (e.g. heparin, heparan sulfate).
2.1.2 Prokaryotic polysaccharide structure. 1D and 2D NMR homo-
and/or heteronuclear spectra have been used for determination of the
linkage and/or structure of the polysaccharides isolated from prokaryotic
cells (see Table 2).
2.2 Peptide/protein-sugar binding (non-covalent interactions)
2.2.1 Eﬀect on peptide/protein. Several NMR techniques including
chemical shift mapping, saturation transfer diﬀerence (STD) NMR
experiment, competition STD, laser photo CINDP and NMR titration have
been employed for identiﬁcation of the binding sites, for analysis of mode
and orientation of binding, and for determination of the dissociation
(or binding) constants of sugars to proteins in protein-sugar complexes. One
or more of these techniques have been used to study binding of several
mono- and disaccharides to the C-terminal domain of an R-type lecitn from
the earthworm Lumbricus terrestris by Hemmi et al.;141 of Neu5Aca2Me to
the carbohydrate-binding cleft mutants of the rotavirus spike protein by
Kraschnefski et al.;142 of the Lewisx trisaccharide to the macrophage
galactose-type C-type lectin 1 by Sakakura et al.;143 of dimeric CD69NG70





















Table 1 Eucaryotic saccharides which structures have been evaluated with the aid of NMR
spectroscopy
polysaccharide type organism reference






wall mannan (eﬀect of oxidative and
osmotic stresses)
Candida albicans serotype A 16




producing, containing a fatty acid
component)
Upis ceramboides 20
(1,6)-b-glucan (cell wall) Saccharomyces cerevisiae 21
dendric sulfated cellobiose cluster
with polylysine
22




glucan of Poria cocos 24
oligasaccharides obtained through
enzymatic synthesis
mannosultransferases from Candida sp. 25
polysaccharide Chroogomphis rutilus fruiting bodies 26
heteroglycan Collema ﬂaccidum 27
polysaccharide Auricularia polytricha fruiting bodies 28
rhamnoglucuronan obtained through
oxidation of gellan exopolysaccharide
29







xylooligosaccharides hydrothermal processing of rice husk 33
lacquer polysaccharide chemically
sulfated
sap of Rus vernicifera 34
acidic galactan Pomarea lineata eggs 35
cyclic b-1,3-heptaglucan Phanerochaete chrysosporium recombin-
ant mutated glycosynthase
36
fructopyranose oligosaccharides fermented beverage of plant extract 37




glucan Rubus crataegifolius roots 40
polysaccharide Amorphophalluscampanulatus corm 41
glucan Pleurotus ﬂorida 42
polysaccharide Launaea acanthodes 43
starch esters enzymatic esteriﬁcation using
Staphylococcus aureus lipase
44
heteropolysaccharide Solenum melongena unripe fruits 45
heteropolysaccharide Amaranthus tricolor stems 46
galactosyl derivatives transglycosylation with b-galactosidase
of Aspergillus orizae
47
exopolysaccharide Tolypocladium sp (fungus, mycelial
fermentation)
48
chondroitin sulfate Scyliorhinus canicula (dogﬁsh) 49
polysaccharides Grifola frondosa (mushroom) 50
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In addition to the usage of some of the above mentioned techniques the
3D solution structure of the protein-sugar complexes have been also cal-
culated with NMR restraints by Shahzad-ul-Hussan et al.145 for chititriose
nad chitotetraose bound to the cyanobacterial lectin MVL; by Koharudin
et al.146 for sucrose bound to LKAMG, the designed chimera of TbCVNH;
by Siebert et al.147 for sialic acid containing oligosaccharides to lectin SHL-
1; by Nesmelova et al.148 for gal-1 in the lactose bound and unbound states.
Competition saturation transfer diﬀerence method combined with











Table 1 (Continued )
polysaccharide type organism reference
polysaccharides Lycopersicon esculentum (unripe tomato) 51
sulfated polysaccharide defatted rice bran 52
cell wall polysaccharides Abelmoschus esculentus (pod of okra) 53




polysaccharide Astragalus membranaceus roots 56
polygalacturonic acid Maytenus ilicifolia leaves 57
heteropolysaccharide Psidium guajava fruits 58
(1-3)-b-D-glucan Dictyophora indusiada fruiting body 59
chitosan polysulfate chemically modiﬁed 60
(1-6)-b-D-glucan Bulgaria inquinans fruiting body 61
phenyl-adducted cyclodextrin 62







b-D-glucan oxidized by 2,2,6,6-tetramethylpiperidine-
1-oxyl radical (TEMPO)
65
deacetylated chitosan chemically derived 66
light-curable chitosan chemically modiﬁed 67
a-1,5-L-arabinobiose released by hydrolase of Fusarium grami-
nearum from plant cell wall
polysaccharide
68
heteropolysaccharide Tremella aurantialba mushroom 69
dextran produced by Leuconostoc mesenteroides
dextranosucrase
70
deprotonated b-cyclodextrin formed in alkaline solutions 71
fucogalactan Ganoderma lucidum fruiting body 72
(1-6)-b-D-glucan Agaricus bitorquis (mushroom) 73
3-O-methylated mannogalactan Pleurotus pulmonarius (mushroom) 74
lignin-type polymers with diﬀerent g-carbon functionality 75






hydrolytic and glycosylated products Aspergillus niger a-glycosidase 78
oligosaccharides from stachylose hydrolysis by Pectinex Ultra 79
arabinoxylan wheat grain 80
glucans Caripia montagnei (mushroom) 81
(1-6)-b-D-glucan Malassezia sympodialis (fungus) 82
mucin-type O-glycans Echinocccus granulosus (cestode) 83
sodium alginate derivatives obtained
after photolytic depolymerization
84










Table 2 Prokaryotic cells saccharides which structures have been established using NMR
spectroscopy
polysaccharide type bacterial strain reference
exopolysaccharides nitrogen ﬁxing bacteria Burkholderia
kukuriensis
89






complete core region from LPS B. cepacia 92
a-glucosides produced by maltose
phosphorylase
Lactobacillus acidophilus 93
O-tetrasaccharide from ﬂagellin Pseudomonas syringae 94
N-tetrasaccharide from ﬂagellin Methanococcus maripaludis 95
O-polysaccharide Salmonella O55 Escherichia coli O103 96
2-branched (1,3)-b-D-glucans lactic bacteria 97
exopolysaccharide Streptococcus thermophilus 98
O-polysaccharides E. coli O123 and Salmonella
enterica O58
99
O-polysaccharides Aeromonas bestiarum strain 207 100
oligosaccharide Arcobacter halophilus 101
O-speciﬁc polysaccharides Azospirilium brasilience sp. 107 and S27
and A.lipoferum RG20a
102
exopolysaccharide Rhizobium sp. 103







O-speciﬁc polysaccharide Hafnia alvei 107
heparosan K5 polysaccharide
(quantiﬁcation in growth medium)
E. coli 108
exopolysaccharide L. johnsonii 109
core oligosaccharide segment of
lipopolysaccharide
Yokenella regensburgei 110
O-polysaccharide Mesorhizobium loti and M. amorphae 111




cell wall polysaccharides Biﬁdobacteriumbiﬁdum 114
O-polysaccharide Yersinia pseudotuberculosis 115
lipopolysaccharide Neisseria meningitidis 116
cell wall glycopolymers Kribbella spp. 117
polysaccharide Vibrio vulniﬁcus 118
O-polysaccharides Providencia alcalifaclens and Proteus
vulgaris
119
exopolysaccharide (evan) Halomonas sp. 120
O-polysaccharide containing abequose Citrobacter freudii 121
O-polysaccharide E. coli 122
exopolysaccharide (pullulan) Aureobasidium pullulans 123
O-polysaccharide Vibrio anguillarum 124
polysaccharides Rahnella aquatilis 125
polysaccharide V. vulniﬁcus 126
polysaccharide V. vulniﬁcus 127
O-polysaccharide Salmonella Mara 128
O-polysaccharide Plesiomonas shigelloides 129
O-polysaccharide Azospirillum lipoferum 99, 130
O-polysaccharide Cronobacter muytjensii 131
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It allows the separation of the STD signals of the labelled reference sugar
ligand from that of the natural abundance hit compound in the case of
strong signal overlap. Diehl et al.150 have shown with 15N spin relaxation
experiments that gelectin-3 backbone exhibits an increase in conformational
entropy upon binding lactose. The cross-polarization with polarization
inversion (CPPI) solid-state experiments have been applied by Patching
et al.151 to study binding of D-glucose to the E. coli sugar transporter Ga1P
and its mutants in membrane preparations. Interaction of lectin B4 of Vicia
villosa with a-D-GalNAc-b3-peptide (a foldamer with antibacterial and
antiproliterative properties) has been analyzed by saturation transfer
diﬀerence (STD) NMR spectroscopy by Kaszowska et al.152
Miller et al.153,154 have used 1H-15NHSQCand pulse ﬁeld gradient (PFG) to
show binding of galectin-1 (lectin) to a-galactomannan Davanat153 and to
prove that carbohydrate-binding domain on human galectin-1 is more exten-
sive for complex glycan than for simple saccharides.154 Sulfated heparin
tetrasaccharide interactions with a complement factor Hmodule 7 (amodel of
glucosaminoglican–protein complex formation) have been analyzed by Blaum
et al.155 using 15N,13C HISQC and H2CN experiments. Ribeiro et al.
156 have
elucidated the principles of lectin-based drug design by developing combined
strategy to identify lead compounds using STD NMR.
2.2.2 Eﬀect on sugar. NMR based conformational studies of a-D-
mannopyranosyl-(1-6)-a,b-D-mannose complexed with Allium sativam
agglutinin I and concanavalin A have been reported by Mazumder and
Mukhopadhyay.157 High resolution real-time NMR has been applied
by Guyett et al.158 in monitoring of intermediates in the conversion of
UDP-a-D-glucoronic acid to UDP-a-D-xylose and UDP-a-D-apiose by a
UDP-apiose/UDP-xylose synthase.
2.3 Sugar-sugar binding (non-covalent interactions)
Weak Ca2þ-mediated interactions between two synthetic trisaccharides,
1-AII and 1-S@Au, have been proven by Santos et al.159 using diﬀusion-
ordered (DOSY) and (TR-NOESY) NMR experiments.
2.4 Sugar to RNA binding (non-covalent)
Zakhour et al.160 have characterised the binding of Gala3GalaOMe to rN82











Table 2 (Continued )
polysaccharide type bacterial strain reference
O-polysaccharide Acinetobacter baumannii 132
co-aggregation receptor polysaccharide Streptococcus oralis 133




O-polyaccharide Taylorella equigenitalis 136
O-polyaccharide Shigella shigelloides 137
lipopolyaccharide Loktanella rosea 138
lipopolyaccharide and lipid A Bacteriovorax stolpii 139
exopolysaccharides Paenibacillus polymyxa 140
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2.5 Sugar binding (non-covalent) to synthetic and natural compounds
1H NMR titration has been used in quantitative binding studies of di- and
mono-saccharides to dimesithylmethane-derived receptors by Mazik and
Buthe.161
1H NMR spectra have been employed to estimate interaction of dextran
with poly(methyl vinyl ether-co-maleic anhydride) nanoparticles by Porﬁre
et al.;162 to analyze the formation of non-inclusion complex between
meglumine antimoniate (antileishmanial drug) and b-cyclodextrin by
Ribeiro et al.;163 and the formation of colchicine:b-cyclodextrin complex,
potential colchicine delivery system for treatment cutaneous diseases, by
Singh et al.164 The same approach has been used by Provencher et al.165 to
test carboxymethylated cyclodextrines (a-, b- and g-) in the presence of
lanthanide ions as chiral NMR solvating agents for aromatic substrates
with phenyl, naphtyl, pyridyl, indoline and indole rings, and by Xin et al.166
to test series of branched cationic b-cyclodextrin derived polymers as an-
ionic drug carriers. The structures of copolymers have been characterized using
1HNMR by Zhang et al.167 for b-cyclodextrin/poly(L-leucine) copolymers; by
Gou et al.168 for miktoarm star copolymer composed of 14 poly(e-capro-
lactone) arms and 7 poly(ethylene glycol) arms with b-cyclodextrin as core
moiety; by Maﬀeo et al.169 to investigate the ability of EDTA-type cyclo-
dextrins (bearing 6, 7 and 8 bis(carboxymethyl)amino(iminodiacetic acid
groups) to coordinate with lanthanide ions (potentially useful as contrast
agents inMRI). 1DNMRhas also been employed byHe et al.170 for structural
characterization of the hyaluronic acid-poly(butyl cyanoacrylate) nano-
particles and by Merceˆ et al.171 for cholecalciferol:b-cyclodextrin complex.
1D together with 2D NMR experiments have been used to characterize
the (S)-7,8-dihydrokavain and b-cyclodextrin inclusion complex by Pesti-
celli et al.;172 to conﬁrm the structures of monoacyl cyclodextrines (a-,
b- and g-) derivatives byMartina et al.173 Various drug:cyclodextrin complexes
have been characterized by the aid of 1D and 2D experiments: the conform-
ation and stability of the N-1-decyl-ferrocenylmethylamine:carboxymethyl-
b-cyclodextrin complex (redox-responsive vesicles) by Zhang et al.;174 the
structure of the N,N’-bis(ferrocenylmethylene)diaminohexane:b-cyclodextrin
complex by Zhang et al.;175 the structure of aspartame:cyclodextrins complex
by Sohajda et al.;176 the structure of the 5,10,15,20-tetrakis(N-methylpyr-
idinium-4-yl)porphyrin:cyclodextrin complex by Mosinger et al.;177 the struc-
ture of the antidepressant trazodone hydrochloride:hydroxypropyl-
b-cyclodextrin complex byMisiuk et al.178A similar approach has been used to
elucidate the structure of various cyclodextrins:risperidone (antipsychotics)
complexes by Danel et al.179 and the structure of biodegradable star polymer
functionalized with b-cyclodextrin inclusion complex by Setijadi et al.180
2D ROESY spectra have been used to elucidate the structure of
cyclodextrin:DNA (pUC18 plasmid) complex as a model delivery system
for gene-therapy by Aachmann et al.;181 the structure of cyclodex-
trin:formoterol (pulmonary drug) complex by Thi et al.;182 the structure of
a complex built of tripod molecule containing an aromatic core bearing
three peracetylated cyclodextrins and pesticide by Mallard-Favier et al.183
and the structure of heptakis-[6-deokxy-6-(2-aminoethylsulfanyl)]:b-
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a-tocopherol:b-cyclodextrin and quercetin:g- cyclodextrin complexes have
been investigated by Koontz et al.185 using 13C CP-MAS NMR.
New types of ligands have been synthesised and their binding properties
to the carbohydrate recognition domain have been studied with competitive
binding NMR method: Stokmaier et al.186 have studied binding of a series
of triazole monovalent ligands to the asialoglycoprotein receptor (ASGP-
R); Murthy et al.187 have studied binding of aromatic mannose disulﬁde
derivatives to concanavalin A.
2.6 Identiﬁcation and quantiﬁcation of sugars
1D and 2D NMR spectra have been used for characterization or identiﬁ-
cation of sugars. With the aid of NMR Toida et al.188 have characterized
oligosaccharides in depolymerised chondrotoin and dermatan sulphates;
Huang et al.189 have characterised the structure of b-(1,4)-linked manno-
pyranoses, the predominant components of the Lan3-2 oligosaccharide
liberated from glycoproteins of Hirudo medicinalis; Volpi and Maccari190
have characterized dermatan sulphate puriﬁed from marine clam Scapharca
inaequivalvis.
1H NMR has been used by Bose et al.191 for quantiﬁcation of sugar
monomers in a modiﬁed hydrolysis procedure of hardwood carbohydrates.
13C NMR has been used for quantiﬁcation of several biological processes:
by Liddell et al.192 to quantify the lactate production in glucose metabolism
under hydrogen peroxide stress in cultured astrocytes.
In vivo 13C NMR has been used by Castro et al.193 to monitor the con-
sumption of a- and b-anomers of the speciﬁcally labelled glucose in diﬀerent
glucose uptake systems as well as to quantify intracellular metabolites
in extracts. 13C CPMAS NMR has been applied by Metzger et al.194 to
quantify the concentration of polysaccharides and proteins in EPS of
Pseudomnas putida nad Aureobasidum pullulans.
Sitkowski et al.195 have applied DOSY experiment for screening heparin
samples for oversulfated chondroitin sulphate contamination.
3 Glycosylated proteins
A subset of glycosylated proteins existing in cells plays speciﬁc glycosyla-
tion-dependent roles. On the other hand structural elucidation of glycosy-
lated proteins is a challenging task because of their complexity and
diversity. Various NMR techniques have been employed in this ﬁeld of
research.
3.1 Glycoprotein structure
For the ﬁrst time a pure arabinogalactan-protein has been isolated by
Go¨llner et al.196 and the primary structure of its sugar part determined with
the aid of 13C NMR. NMR methods have been used Yoshida-Moriguchi
et al.197 for identiﬁcation of a phosphorylated O-mannosyl glycan on the
mucin-like domain of recombinant a-DG. Interaction surfaces between
domains of ﬁbronectin have been identiﬁed by Vakonakis et al.198 from
chemical shift perturbations measured in 1H-15N HSQC spectra. The
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et al.199 using combination of 1H, 13C and 31P NMR. The structure of
3 disialyl-Lex hexaccharide antigen of human colorectal cancer has been
proposed by Robbe-Masselot et al.200 with the aid of COSY spectra. The
eﬀect of glycosylation on the cis/trans isomerisation of prolines of the hinge
peptide of human serum immonoglobulin A1 has been analysed by
Narimatsu et al.201 with 1H-13C HSQC NMR.
Segmental 13C/15N labelling of protein but not carbohydrate moiety has
enabled Slynko et al.202 determination of the structure of N-linked glyco-
protein of Campylobacter jejuni using 2D 13C-ﬁltered-ﬁltered NOESY.
Cle´ment et al.203 have characterized the structure of fucoidan from brown
algae using 1D and 2D NMR while its interaction with the protein C4 (of
human complement system) has been analyzed using STD-NMR and
TRNOESY experiments. Human galectin-1 and galactose-containing lig-
ands structures have been analysed using 1H-15N HSQC NMR experiments
by Meynier et al.204
3.2 Glycopeptides
2D homo- and hetero-nuclear NMR spectra have been used by Matsushita
et al.205 to solve the 3D structure of MUC1-related N,O-glycopeptide and
its two O-glycopetide fragments. Temperature coeﬃcients of amide protons
have been measured by Tam et al.206 in their studies of solution conform-
ation of C-linked antifreeze truncated glycoprotein AFGP-8 analogues. A
series od monoglycolsylated antifreeze glycopeptides analogues have been
synthesised by Heggemann et al.207 and their structures conﬁrmed with
NMR. Lu et al.208 have determined the structure of a new antifungal gly-
copeptide of Burkholderia contaminans with 2D NMR and Wu et al.209
using 13C and HMBC spectra have elucidated the structure of Ganoderma
lucidum fruit glycopeptide with sugar dependent antioxidant activity.
4 Proteins/peptides – lipids interactions in the membranes
For many years biological membranes were considered to be a passive
structural scaﬀold for interacting and even embeded proteins. Development
of new NMR techniques made studies on the lipid-protein interaction
feasible revealing the existence of dynamic structural equilibrium between
both counterparts. Recent studies using simpliﬁed model lipid-protein
interacting systems and also natural partners interactions are summarized
below.
4.1 Eﬀect on lipid
Russel-Schulz et al.210 have used 2H solid state spectroscopy to study per-
turbation of DPPC/POPG bilayers by SP-B8–25, a synthetic peptide com-
prising the N-terminal helix of the essential lung surfactant protein. POPC/
POPG membrane perturbation caused by the human cathelicidin anti-
microbial peptide LL37 has been studied by Thennarasu et al.211 with the
aid of 31P SSNMR. Changes in the solid state 13C and 31P chemical shifts
and decrease of the corresponding T1 relaxation time have been observed by
Ausili et al.212 for phosphatidylglycerol unreached membranes upon the
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membrane penetration of the NPY analogue, paramagnetic [Ala31,
TOAC32]-NPY, have been studied by Thomas et al.213 with 1HMAS NMR.
In the case of zwitterionic phospholipids and charged lipids NPY was lo-
cated in the upper chain region and in the head group region of membrane,
respectively.
The eﬀect of mycosubtilin on phase transition of DPMC has been
checked by Nasir et al.214 with HR-MAS NMR. The DMPC and DMPG
supramolecular organization and phase transition upon interactions with
penetratin and antimicrobial RL16 peptide have been monitored by Alves
et al.215 with 31P SSNMR. Membrane disordering eﬀect has been studied
for the series of histidine-rich amphipathic cationic peptides with 2H
SSNMR by Mason et al.216 It has been shown by Vostrikoy et al.217 using
2H SSNMR that the introduction of a single arginine residue into a
hydrophobic TM helix results either in a small reorientation of the helix or
in a dynamic switching between TM and interfacial orientations of the helix.
Yang et al.218 have used the same techniques to study the eﬀect of a
C-terminal peptide of surfactant protein B on mechanically oriented POPC/
POPG bilayers. The inﬂuence of the pore-forming cytolysin, equinatoxin II
on the lipid order and bilayer morphology of multilamellar vesicles has been
investigated by Dreschler et al.219 with 31P and 2H solid-state NMR.
Interactions of the gp144 lytic transglycosylase with DPMC and DPMG
membranes have been studied using 2H and 31P SSNMR by Cloutier et al.220
Using these techniques Antharam et al.221 have shown that the C-terminus of
lung surfactant protein B alters lipid organization in DPPC/POPG and
POPC/POPG lipid systems. The structure andmotions of several membrane-
mimetic systems have been studied in the presence of the HIV fusion peptide
(HFP) constructs by Gabrys et al.222 with the aid of 2H and 31P SSNMR;
the HFP-induced membrane curvature was observed. The interaction of
pardaxin with zwitterionic and anionic vesicles have been studied by Vad
et al.223 using 13C PISEMA. Location of two diﬀerent potassium channels,
the KvAp and HsapBK in DMPC/DHPC micelles and POPC vesicles has
been studied by Biversta˚hl et al.224 using 13C and 2H SSNMR.
Attenuation of signals in 1H NMR spectra of POPC/POPG membranes
embedded with voltage-sensing domains has been used by Krepkiy et al.225
to study membranes structure and hydration. The equilibrium between oleic
acid free and bound to equine lysozyme in ELOA complex has been studied
by Nielsen et al.226 using 1H NMR.
1D and 2D NMR have been used by Marty et al.227 to search for a
membrane-binding motif of the chloroplast signal recognition particle re-
ceptor and to analyze its interaction with lipids and by Gouttenoire et al.228
to characterize the amphipathic segment (a-helix) responsible for membrane
association of hepatis C virus (HCV) protein 4B using deuterated micellar
dodecylphospholine or deuterated triﬂuoroethanol as membrane mimetic
medium. Tong et al.229 have resolved the conformation of the GD2 gang-
lioside (targeted for cancer diagnosis, prognosis and therapy by antibody
mAb 3F8), free and bound to mAb, by STD NMR and various 2D
experiments. Lesovoy et al.230 have analyzed binding of recombinant
neurotoxin II from Naja oxiana with liposomes (DOPC/DOPS/CHO) using
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Solid-state MAS 31P NMR has been used by Sani et al.231 to track ex vivo
the behaviour of mitochondrial membrane lipids (PE, PC, Cl) during
physiological processes; by Cheng et al.232 to analyze the eﬀect of anti-
mirobial peptides (aurein) on perturbation of lipid headgroups of the
bilayers (PMPC/DMPG and POPC/POPG); by Nakazawa et al.233 to study
the mode of interactions of amyloid b peptide (Ab) with DMPC mem-
branes. Similarly, Madine et al.234 have elucidated the eﬀect of a-synuclein
on PC/PG vesicle integrity using 31P NMR. The eﬀect of membrane-fuso-
genic ‘Leu-Val’ peptides (mimicking natural transmembrane peptide se-
quences) on the changes of phospolipid (POPC/DOPS/DOPE) phase order
has been elucidated by Agrawal et al.235 using solid-state 1D 31P NMR and
2D NOESY experiment.
Solid-state 2H NMR has been used by Jean-Franc¸ois et al.236 to elucidate
the eﬀect of cateslytin, antimicrobial peptide, on model membrane (DMPC/
DMPG/ERG) structure; by Pabst et al.237 to observe the perturbation of
PG bilayers (membrane thickness) caused by the antimicrobial peptide
peptidyl-glycylleucinecarboxyamide. Solid-state 31P and 2H NMR have
been used by Kim et al.238 to observe the antimicrobial peptides (magainin-2
and aurein-3) induced formation of pores of thinned lipid bilayer.
Interaction and dynamics of a 21-mer cytotoxic peptide (that acts as ion
channel) with phospholipid (DMPC or DPPC)/DHPC bicelles have been
elucidated by Ouellet et al.239 with solid-state 2H, 13C, 15N and 31P NMR.
De la Serna et al.240 have investigated the lipid dynamics in the pulmonary
surfactant membranes reconstituted from the lung surfactant hydrophobic
components (lipids and proteins) using pulse-ﬁeld gradient 31P NMR. Lind
et al.241 have analyzed the eﬀect of two model peptides with diﬀerent
hydrophobic length on the phospholipid dynamics in diﬀerent bicelles
using natural abundance 13C relaxation measurements; diﬀusion constants
were measured using a modiﬁed Stejskal-Tanner spin-echo experiment.
4.2 Eﬀect on peptide/protein
The intact transmembrane domain from human amyloid protein precursor
(APP), hAPP-TM has been produced and puriﬁed in the amount suﬃcient
to measure its NMR spectra in DPC micelles by Park et al.242 The 3D
structure and orientation of rat IAPP in DPC micelles have been studied by
Nanga et al.243 by solution NMR. Smith et al.244 with the solid-state NMR
have conﬁrmed that hIAPP binds to the regions of negative curvature in
bicelles. Grimaldi et al.245 have probed conformational dependence of the
amyloid peptide, Ab(16–35) in the response to negative charge modiﬁ-
cations of the micelle surface. Sato et al.246 have shown that the amyloid
precursor protein transmembrane (APP TM) helix is disrupted at the
intracellular membrane boundary near e-cleavage site. Structures of rat
and human IAPP1–19 in DPC micelles have been determined by Nanga
et al.247 Park et al.248 have charcterised bovine antimicrobial peptide
lactophoricin in DPC micelles using 1H-15N HSQC spectra.
The temperature dependence of the partition coeﬃcient of an eleven
amino acids peptide, substance P in isotropic bicells has been studied by
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Vermeer et al.250 using 13C solid state NMR have shown that the TM7
segment of subunit a from Hþ -V-ATPase from Saccharomyces cerevisiae is
immobile in phospholipid bilayer.
Changes in the 1H NMR spectra of the N-terminal region of CGI-58
upon DPC titration measured by Gruber et al.251 revealed strong protein-
micelle interaction. Chemical shift perturbations of Ca, Cb and HN of acyl
carrier protein from Plasmodium falciparum substantiate with NOE eﬀects
have been used by Upadhyay et al.252 to analyze the interactions of
ACP molecule with the acyl intermediates in the fatty acid synthesis
pathway. Evans et al.253 using chemical shift perturbations and 2D homo-
and hetero-nuclear spectra have calculated a series of 3D structures of the
derivatised act ACPs from S. coelicolor A3(2) bound with diﬀerent mimics
of early polyketide intermediates.
3D NMR solution structures of E. coli apo-ACP, acyl-ACP and butyryl-
ACP have been solved by Wu et al.254 and by that means the conforma-
tional dependence of the protein on the ligand size has been revealed. The
solution structure of an ACP domain from a fungal type I polyketide
synthase has been solved by Wattana-amorn et al.255
Chemical shift perturbations have been used to investigate the inter-
actions of ATP with cytochrome c and its E26N mutant by Patriarca
et al.256 (using 1H, 15N of amide groups); of a small antimicrobial ‘PFR’
peptide with SDS and DPC micelles by Zorko et al.257 (using Ha).
The orientation of the heterodimeric antimicrobial peptide in the mem-
brane has been determined by Resende et al.258 using 2H solid state NMR.
Orientational distributions of monomeric membrane-bound peptides have
been predicted theoretically by Esteban-Martin et al.259 and validated by
comparison of the predicted 2H solid state NMR quadrupolar couplings
with experimental ones. Strandberg et al.260 have studied synergistic
transmembrane insertion of the heterodimericPGLa/magainin 2 complex
using 2H solide-state NMR and peptides labelled with Ala-d3 in diﬀerent
positions. Rui et al.261 have simulated orientation of protegrin-1 monomer
and dimer in DLPC and POPC bilayers. The tilt angle of hCB1(T377-E416)
within the phospholipid bilayer has been determined using six single 15N-
labelled peptides and 15N solid phase NMR by Tiburu et al.262 The results
of Ellena et al.263 studies of the structure and dynamics of Syb(1-116) in
lipid micelles have indicated the presence of helical propensities in the
TM domain and at the beginning and end of the SNARE motif.
Using diﬀerent liquid or solid state NMR experiments the 2D and/or
3D structure, dynamics and/or interactions of peptides/proteins with
membrane have been revealed: of kisspeptin decapeptide analogs bound to
POPC by Lee et al.;264 of bradykinin bound to DOPC/DOPE by Bonechi
et al.;265 of Ste11SAM bound to DPC by Bhunia et al.;266 of RP-1 anti-
microbial peptide bound to DPC by Bourbigot et al.;267 of Gp41 peptide P1
bound to DPC by Coutant et al.;268 of hedistin in DPC micelles by Xu
et al.;269 of the N-terminal region of equinatoxin II bound to several
membranes by Drechsler et al.;270 of the isolated voltage-sensing domain
of the potassium channel KvAP bound to DPC/LDAO by Shenkarev
et al.;271 of the potassium channel KcsA-Kv1.3 embedded in asolectin
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peptide embedded into DPC micelle by O’Daniel et al.;273 of Ser-16 phos-
phorylated phospholamban in mechanically oriented DOPC/DOPE by
Chu et al.;274 of the N27A phospholamban in MLVs by the same group;275
of oxidized and reduced y1fatc, the FATC domain of yeast TOR1, bound to
membrane-mimetic bicelles by Dames;276 of Pa4 pardaxin in LPS micelles
by Bhunia et al.;277 of EphA2 transmembrane domain embedded in DPMC/
DHPC bicelles by Bocharov et al.;278 of the hinge deleted melittins in
DPC micelles by Saravan et al.;279 of lung surfactant peptide KL4 in POPC/
POPG and DPPC/POPG lipid vesicles by Long et al.;280 of the antifungal
Psd1 pea defensin with PC, DPC and CMH vesicles by de Medeiros et al.;281
of sticholysin I with DPC by Castrillo et al.;282 of the intra-membrane
histidine kinase Ybdk TM domain in DPC micelles by Kim et al.;283 of
several neuropeptides and their analogues in DPC micelles by Zdobinsky
et al.;284 of HIV-1 virus protein U cytoplasmic domain in DPC micelles by
Wittlich et al.;285 of the dengue virus fusion peptide in DPC micelles by
Melo et al.;286 of a double transmembrane fragment of a G-protein coupled
receptor in LPPG micelles by Neumoin et al.;287 of the PC1/3 DCSG-
sorting domain in CHAPS micelles by Dikeakos et al.;288 of the critical
transmembrane segment XI in DPC micelles by Lee et al.;289 of the
4F antiatherogenic peptide in DMPC discs by Mishra et al.;290 of CD4mut
comprising the human CD4 transmembrane and cytoplasmic domains in
DPC micelles by Wittlich et al.;291 of Nogo-66, the extracellular domain in
DMPC vesicles and DPC micelles by Vasudevan et al.292
Haney et al.293 have reviewed solution structures of amphibian anti-
microbial peptides in the presence of membrane mimetic micelles or bicelles
obtained with solution NMR. Thomas et al.294 have systematically studied
using 2H SSNMR the extent of helix kink caused by a single proline within
the isolated TM helical domain of WALP19 in DOPC, DPMC or DPLC.
The inﬂuence of membrane curvature (in the order: MLV, SUV, DPC, DM)
on the structure of the phospholipase C-d1 pleckstrin homology domain has
been investigated with the aid of 13C SSNMR by Uekama et al.295
The secondary structure of the cav-1(94-102) juxta-membrane segment
of caveolin-1 in interaction with various membrane models has been
determined by Le Lan et al.296 using 2D NOESY and proton/deuterium
exchange experiments. In addition, the localization of the peptide in DPC
micelles has been established with intermolecular NOEs. Water-accessible
residues in the trasmembrane b-barell of OmpX in DHPC solution have
been mapped by Catoire et al.297 with hydrogen/deuterium exchange
measurements. The secondary structure of TM2-GABAA peptide within
the phospholipid bilayer has been determined by Kandasamy et al.298 with
the aid of REDOR experiments and its orientation in membrane has been
measured with 2D PISEMA. Salnikov et al.299 using 2D 15N-d vs. 1H-15N
dipolar coupling solid–state NMR correlation spectroscopy have found that
ampullosporin A and alamethicin adopt mixed a/310-helical structures in
their trans-membrane conﬁguration. Location of HIV fusion peptide and its
cross-linked oligomers in cholesterol-containing membranes have been
studied by Qiang and Weliky300 using 13C-31P REDOR. The same group
has compared the structures of FP34, N70 and FP-hairpin constructs of
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and in membranes without cholesterol using REDOR spectra.301 The eﬀects
of anesthetics on the tilt and rotational angles of TM2 helices (the second
transmembrane domains of the neuronal a4b2 nicotinic acetylcholine
receptor) in magnetically aligned 14-O-PC/6-O-PC have been observed by
Cui et al.302 in PISEMA spectra. Cholesterol has been found to reduce
pardaxin’s dynamic and tilt in phospholipid membrane by Ramamoorthy
et al.303 using BB-PISEMA.
It has been shown by Williamson et al.304 in studying amyloid
polypeptide, IAPP binding to lipid using CPMG that the amount of helix
formed aﬀects the rate of amyloid assemble.
Temperature-dependent relaxation study (1H T1r) of membrane-bound
inﬂuenza A M2 transmembrane peptide carried out by Cady and Hong305
has revealed amantadine induced better puckering of peptide tetramers. The
same group have used 13C and 15N SSNMR to show the role of Ser31 in
amantadine binding and its inﬂuence on the bound peptide structure306 and
13{C2H} REDOR to establish a 0.3 A˚ resolution structure of this binding
site.307
Duchardt et al.308 using 2D ROESY and NOESY techniques have
demonstrated that the cyclic form of a cell-penetrating peptide from the
N-terminal domain of human lactoferricin undergoes a conformational
transition when interacting with heparan sulphate proteoglycans.
Solid-state 13C-13C correlation spectroscopy of membrane (DTPC/
DTPG) associated inﬂuenza virus fusion peptide, IFP, has been used by Sun
and Weliky309 to conﬁrm the existence of helix-turn-helix motif and pH
dependent two conformational states of the peptide.
Bodner et al.310 using 1H-15N HSQC, lipid-to-amide NOE transfer
experiments, 15N TROSY experiments for R2
T measurements and PFG
NMR experiments have found that a-synuclein binds to DOPE/DOPS/
DOPC SUVs with stable multiple competitive modes depending on lipid/aS
stoichiometry. The same group have viewed the phospholipid binding
properties of the disease variants of a-synuclein using solution NMR
methods.311
From the combined use of solid state NMR and MD simulations a large
structural ﬂexibility has been concluded by Vogel et al.312 for the peptide
that represents the terminal seven amino acids of human N-Ras protein
in DPMC. SSNMR and MD studies performed by Lam et al.313 for
equinatoxin II N-terminus in DPMC and DPMC/SM bilayers have
indicated signiﬁcant environment dependent secondary structure diﬀerences.
Selective labelling has been used by Lange et al.314 to monitor the nucleotide
binding site of the bacterial ABC transporter ArtMP in nucleotide-bound
or –unbound states in native lipid environment.
15N chemical shift tensors have been used by Chemenkev et al.315 to
investigate fast in-plane motions of piscidin along the membrane surface.
Diﬀerent binding modes to DPC micelles for diﬀerent cyclotides have been
found by Wang et al.316 It has been postulated by Vos et al.317 that NMR
spectroscopy yielding high-resolution structure at atomic level should be
complemented with other ‘low resolution data’ in order to properly describe
membrane-bound proteins; ‘I’ and ‘L’ states of M13 protein served as an
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SAXS methods of an integral membrane protein interactions with diﬀerent
detergents carried out by Columbus et al.318 have suggested that the
completeness of the NMR observations depend on the matching of the
micelle dimensions to the proteins hydrophobic surface.
SSNMR approaches used to study topological equilibria and dynamics of
membrane peptides have been reviewed by Salnikov et al.319
The 3D structure of the SARS coronavirus envelope protein channel in
DPC micelles has been established by Pervushin et al.320 using several NMR
techniques including paramagnetic probes and residual dipolar couplings.
Activation energy of excited state (T- to R-state transition) of the integral
membrane protein phospholamban DPC-bound has been measured using
CPMG at diﬀerent temperatures by Traaseth and Veglia.321 The secondary
structure and dynamics of green proteorhodopsin in DPMC/DPMA
environment have been analyzed by Shi et al.322 with the aid of 3D and 4D
MAS SSNMR spectroscopy. Using 2D SSNMR diﬀerence spectroscopy for
rhodopsin/transducer (SRII/HtrII) complex from Natronomonas pharaonis
in a natural membrane environment Etzkorn et al.323 have identiﬁed resi-
dues that may act as a functional module around the retinal binding site
during the early events of protein activation. The use of 2H SSNMR
methods used for study interactions of the retinal cofactor with rhodopsin
in detergent micelles has been reviewed by Brown et al.324 The binding of
rhomboid protease from Pseudomonas aeruginosa to lipid membranes
(DDM, DPC, LMPC, LPPG) has been studied with 1H-15N HSQC by
Sherratt et al.325 The CRINEPT-TROSY experiment designed to provide
1H-15N correlations has been used for the ﬁrst time by Caillet-Saguy et al.326
to characterise a large holo- and apo-HasA-HasR complex in DPC micelles.
The 3D structure of Rv1761c (127 residues) from Mycobacterium tubercu-
losis in DPC micelles has been determined by Page et al.327 The binding
between human proﬁlin I and inositol 1,4,5-triphosphate has been investi-
gated by Richer et al.328 with NMR titration experiments. Veldkamp
et al.329 have shown that DMPC/DHPC bicelles promote dimerization of
SDF-1 protein. Barbar et al.330 have analyzed the eﬀect of cholesterol
binding on the structure of steroidogenic acute regulatory (StAR) protein
structure by using solution-state 1H-15N HSQC spectra.
4.3 Simultaneous elucidation of the eﬀects on lipid and protein
Solution NMR has been used by Bourbigot et al.331 to determine the
structure of an antimicrobial peptide IL-8a in SDS micelles, and solid-state
31P, 15N and 2H NMR to probe the interaction of the peptide with oriented
POPC/POPG bilayers. No evidence of bilayer disruption was found in this
case. The eﬀect of the dermadistinctin K on the organisation of the lipid
bilayer with 31P solid-state NMR has been studied by Verly et al.332 and the
alignment of the peptide within a lipid membrane has been investigated by
15N solid state NMR. Antharam et al.333 have analyzed the secondary
structure of KL4 peptide interacting with lipid bilayers and studied the eﬀect
of KL4 on lipid head-group interactions and lipid acyl chain dynamics with
31P NMR and 2H NMR, respectively. 3D structures of C-terminal
analogues of human b-defensin-3 in the presence of DPC/POPG micelles
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lipid phase partition of the peptides has been characterized with DOSY
experiments. The 2D heteronuclear NMR spectra in lipid nanodiscs have
been reported for an IMP byGlu¨ck et al.;335 for VDAC-1 by Raschle et al.336
To ensure that the functionally active state of an IMP protein is present in
the conventional membrane mimetic, Shenkarev et al.337 have proposed as a
reference the 2D 1H,15N-ﬁngerprint of a protein measured in a lipid-protein
nanodiscs. Morrissey et al.338 have reviewed usage of solid-state NMR in
combination with nanodiscs as a platform for blood clotting proteins-
membrane interactions.
13CO-31P and 13CO-(16-19F) REDOR have been applied by Qiang
et al.339 to trace membrane locations for several diﬀerent HIV fusion
peptide constructs. Charge- and hydrogen bond stabilized interactions of
side-chains of Arg and Lys residues of a cell-penetrating peptide with the
lipid phosphate groups have been analysed by Su et al.340 with the aid of
13C-31P REDOR. It has been shown by Tang and Hong341 using a variety of
solid-state NMR techniques that PG-1, the arginine-rich-b-hairpin anti-
microbial peptide, causes toroidal pore defects in the anionic membrane
and, in addition, that the peptide structure is membrane dependent. The
Arg-depleted PG-1 mutant (D4,18 G10) has been shown by the same group
342
to form incomplete insertion of the peptide at the membrane surface.
Bhattacharjya and Ramamoorthy343 have reviewed the mechanisms of
action of two highly potent helical antimicrobial peptides, MSI-78 and
MSI-594, with membrane. They discussed peptide structure-function
correlations at the atomic level on the basis of NMRdata. Solid state 15N and
31P NMR have been applied by Chenal et al.344 for studying pH dependence
of the diphteria toxin T domain interaction with POPC/POPG bilayer.
Proteorhodopsin has been reconstituted in DPMC/DMPA liposomes by
Shi et al.,345 and 13C and 15N backbone and side-chain chemical shifts for
103 out of 238 residues of this protein were assigned. The stability of CCR5
functionally reconstituted in rHDL has been shown by Yoshiura et al.346 to
be suﬃcient for methyl directed transferred cross-saturation (TCS) experi-
ments for studying CCR5 with MIP-1a ligand interactions. 2H and 31P
NMR have been used by Meier and Seelig347 for investigation of the eﬀect
of the detergents of the n-alkyl-b-D-glucopyranoside class on the ordering of
lipid bilayers and dynamics of membrane-embedded peptides.
5 Lipidated proteins
Besides primary amino acid composition also posttranslational lipidation of
proteins is substantial for their hydrophobicity. The resulting biological
eﬀects are thought to be crucial for the association of lipidated protein with
the cellular membranes as well as for protein-protein interaction, protein
folding and stability. Additionally, the reversibility of the lipidated protein –
lipid membrane association still remains a point of debate. Several recent
papers have been focused on these topics.
It has been shown by Mascioni et al.348 using 3D 15N-edited NOESY
spectra and paramagnetic 5-doxyl stearic acid that the folded portion of the
Pam3Cys lipidated rLP2086-B01 anchored to the micelle does not interact











Nucl. Magn. Reson., 2011, 40, 344–390 | 359
becomes a pH sensor upon lipidation. High resolution NMR spectra have
been obtained by Valentine et al.350 for myristolyated recoverin and HIV-1
matrix protein both encapsulated in riverse micelles.
Dynamic properties of lipidated outer membrane protein LP2086-B01
with those of the non-lipidated free protein in solution have been compared
by Mascioni et al.351 using T1, T2 and 15N(1H)NOE experiments. Epand
et al.352 using 31P SS NMR have identiﬁed for the ﬁrst time phosphatidic
acid as one of the lipids bound to the bovine mitochondrial ADP/ATP
carrier. Scheidt et al.353 have used 2H (powder spectra) and 31P NMR (static
spectra) to investigate the structure and dynamics of the myristoyl chain of
myr-Src (tyrosine kinase) in phospholipid bilayers. Interaction of N-
terminally acetylated peptide (used as a proxy for the phospholamban PLB)
with the surface of the DMPC/DOPG membranes has been analyzed by
Hughes et al.354 using wide line 2H and 31P MAS NMR. Liu et al.355 have
presented the structure of myristoylated ADP-rybosylation factor1 (ARF1)
and an assessment of the inﬂuence of myristoylation on association
of ARF1 with lipid bilayer by solution NMRmethods (13C excited CCmHm-
TOCSY, NOESY-15N HSQC, HNHA, 1H1H TOCSY-15N HSQC experi-
ments). The structure of C15-surfactin-O-methyl ester, surface active lipo-
peptide produced by Bacillus subtilis, has been established using 1H and 13C
NMR by Liu et al.356
Brunsveld et al.357 have summarized the literature data on membrane
binding of lipidated Ras peptides and proteins, among other methods
solid-state 2H and 31P MAS NMR have been discussed.
6 Lipoproteins (non-covalent complexes)
Lipoprotein complexes are important objects of structural studies because
of their involvement in both intercellular lipid transport. Modulation of
these processes might lead to the development of pharmacologically
important protocols (e.g. hypercholesterolemia diagnosis and treatment). A
number of publications have been devoted to elucidation of these problems.
A series of loihichelins A-F, siderophores produced by the marine bac-
teriumHalomonas LOB-5 have been characterized by Homann et al.358 with
the aid of proton and proton-carbon spectra. The structure of the
ApoE(130-149)-CR17 fusion construct has been solved with NMR data and
the minimal interface between both parts has been characterized with
changes in chemical shifts by Guttman et al.359 Sinnaeve et al.360 have ap-
plied 3JHH couplings to show that the conformation of the backbone of the
cyclic lipodepsipeptide Pseudodesmin A does not change between two
solvents chloroform and acetonitrile. The binding mode of the domain V
of plasma protein b2GPI with four LA modules from the low-density
lipoprotein receptors LDLR and ApoER2 has been studied by Lee et al.361
1H NMR has been used by Carr et al.362 to measure lipoprotein subclass
particle concentration (diﬀerent class produce a distinct methyl signal
whose amplitude is directly proportional to lipoprotein particle concen-
tration); by Wang et al.363 to estimate the amount of low- and very
low-density lipoproteins in rat serum after exposure to chlorpyrifos and
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concentration after acute ﬁsh oil consumption; by Mora et al.365 to elucidate
the lipoprotein particle proﬁles (size and number) as a potential cardio-
vascular disease clinical marker. The same group366 has elucidated the
lipoprotein particle proﬁles (size and number) in association with clinical
type 2 diabetes.
Intercellular lipid transport has been addressed by the study on the
structure of lipid binding protein. Zornetzer et al.367 have analyzed the eﬀect




7 Lipids and membranes
Biological membranes play dual role in living cells - they protect cell in-
tegrity and simultaneously constitute the permeable barrier responsible for
nutrients supply and environmental signal transmission. These functions are
secured by speciﬁc membrane composition. Many researchers exploited
various NMR techniques to elucidate structural and functional aspects of
natural and model lipid membranes and hydrophobic cellular components.
7.1 Lipid structure and dynamics
1D and 2D NMR have been applied for structural elucidations: to estimate
the structure of uvaol (triterpene) and other lipids of Carpobrotus edulis
(inhibitors of the P-glycoprotein - the eﬄux pump responsible for the
multidrug resistance of malignant cells) by Martins et al.;368 to describe the
structure of dehydrocostus lactone, proapoptotic component of hexane
extract of Saussurea lappa Kim et al.;369 to identify the structure of myelin
penta- and hexa-acetyl-galactosyl-ceramides from rat brain by Podbielska
et al.;370 to describe the structures of 16 dihydro-b-agarofuran sesqui-
terpenes, potential modulators of P-glycoprotein dependent multidrug
resistance by Torres-Romero et al.;371 to elucidate the structure of noso-
komycins, new antibiotics produced by Streptomyces sp. by Uchida et al.;372
to identify the structures of chemically synthesized fourteen ursolic acid and
oleanolic acid saponins (with N-acetyl-b-D-glucosamine oligasaccharide
residues) by Wang et al.373
Capyk et al.374 have identiﬁed the hydroxyl group at carbon-26 of
cholesterol derivative molecule by 1D NMR which conﬁrmed the classiﬁ-
cation of mycobacterial cytochrome P450 125 as a steroid C26-hydroxylase.
1D and 2D spectra have been used by Nguyen et al.375 to identify the
structure of 17,20,24-trihydroxyvitamin D2 – product of human cyto-
chrome P450scc. A similar approach has been used by Tuckey et al.376 to
elucidate the structure of 1a,20-dihydroxyvitamin D3 – product of human
cytochrome P450scc. Analogous experiments have been performed by
Makarieva et al.377 to elucidate the structure of isorhizocchalin, a bipolar
sphingolipid of Rhizochalina incrustata; by Ohnuki et al.378 to establish the
structures of haplofungins, inositol phosphorylceramide synthase inhibitors
from Lauriomyces bellus; by Bao et al.379 to establish the structures of bi-
cyclic a,o-dicarboxylic acid derivatives from a colonial tunicate; by Sandjo
et al.380 to determine the structures of terpenoid derivatives from the leaves
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glandular trichome exudate of Paulownia tomentosa by Asai et al.;381 the
structures of acetylenic fatty acids, triterpenes and trigliceride from the
leaves of Hymenodictyon excelsum by Nareeboon et al.;382 the structure of
C37 skeletal carotenoid from the clam, Paphia amabilis by Maoka et al.;
383
the structure of the etheroleic acid as a predominant product of linoleic acid
metabolism by divinyl ether synthase of the Lily-of-the-Valley roots by
Ogorodnikova et al.;384 by Gaenko et al.385 to elucidate the structure of
lipid components of Clostridium butyricum spores (with antitumor activity);
by Tayone et al.386 to determine the structure of achaetolide, poly-
hydroxylated 10-membered macrolide, of Ophiobolus sp.; by Whitson
et al.387 to establish the structures of ﬁbrosterol sulfates (sulfated sterol
dimers with an inhibitory activity against protein kinase C) of the sponge
Lissodendoryx ﬁbrosa; by Morinaka et al.388 to identify the structures of
amaroxocanes, sulfated dimeric sterols of the sponge Phorbas amaranthus;
and by Qin et al.389 to determine the structures of globosterol, poly-
hydroxylated steroid of the fungus Chaetomium globosum.
The following structures have been elucidated with the aid of 1D and 2D
NMR spectroscopy: of cholesterol carboxyaldehyde formed upon reaction
of cholesterol with singlet molecular oxygen and ozone by Uemi et al.;390 of
two prenylated ﬂavonoids, potential inhibitors of acyl-coenzyme A:chol-
esterol acyltransferase by Choi et al.;391 of 13-cis-retinoyl ferrocene
derivatives by Long et al.;392 of four novel oxylipins of the corn of
Dracontium loretense byBenavides et al.;393 of chlorosulfonolipids of the alga
Ochromonas danica by Kawahara et al.;394 of diterpenoid, multidione, from
the stems of Jatropha multiﬁda byDas et al.;395 of the ascorbate-polyethylene
glycol-DSPE conjugate (potential pharmaceutical nanocarrier) by Salmaso
et al.;396 of the products formed in vitro by soybean lipoxygenase by Zheng
et al.;397 of tanacetamide D, a ceramide from the leaves of Tanacetum
artenisioides by Hussain et al.398 and the structures of six lipidyl pseu-
dopteranes of coral Pseudopterogorgia acerosa, potential inhibitors of
protein tyrosine phosphatase by Kate et al.399
The structures of chlorosulfonolipids of the alga Ochromonas danica
have been determined by Bedke et al.400 using 1H,13C NMR and 2D
HETLOC and HSQMBC experiments.
Ohyama et al.401 have elucidated the biosynthetic pathway of phytosterol
in Arabidopsis thaliana by estimation of the structure of the metabolically
labelled sterols using 1H,13C and 13C-{1H}{2H}NMR.
Phospholipid composition of human lenses has been re-evaluated by
Estrada et al.402 using 31P NMR, and lipid composition of bull muscles has
been analyzed by Dannenberger et al.403 using 13C NMR. Gylfason et al.404
have analyzed the phospholipid composition of lipid rafts isolated from
brush border membrane of Atlantic cod with 31P NMR, and Frederick
et al.405 analyzed the morphology and organization of hydrated dispersions
of dioleoyl-bis(monoacylglycero)phosphate with wide line 31P NMR.
The structure of chemically synthesized lipid derivatives has been studied,
e.g. Cui et al.406 have estimated the structure of chemically synthesized
methyl esters of eicosapentaenoic acid monoepoxides, Hojabri et al.407 have
characterized the fatty-acid derived diisocyanate and biobased poly-
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(using selenium dioxide) allylic hydroxylated derivatives of the C18
unsaturated fatty acids, Banday et al.409 have determined the structures of
various chemically synthesized cholesteryl esters. Rawling et al.410 have
described the stereoselective synthesis of monounsaturated o-3 fatty acids
and analyzed their structure using 1H-13C HSQC experiment. Lessig and
Fuchs411 have followed the chemical (HOCl-mediated) degradation of
unsaturated plasmalogens in PC membranes by using 31P NMR. Guille´n
et al.412 have elucidated the degradation process of the sunﬂower oil upon
frying by estimation of the structure of its component-linoleic acid using 1H
NMR. Baillif et al.413 have investigated the fatty acid elongation and
desaturation steps in Fusarium lateritium by determination of the structure
of methyl linoleate by quantitative 2H-{1H}NMR in isotopic and chiral
oriented solvents. Kooijman et al.414 have investigated the pH-dependent
ionization of phosphatidylinositol bi- and triphosphates in mixed PI/PC
membranes using 31P MAS NMR.
7.2 Lipid – lipid interactions
31P NMR has been used by Ahyayauch et al.415 to analyze the composition
of the PC/SM/CHO membranes, by Garcı´a-Pacios et al.416 to analyze
the interaction of sphingosine-1-phosphate with DEPE membranes, by
McMullen et al.417 to examine the eﬀect of cholesterol on the structure and
organization of the PG membranes. The size and morphology of small
bicelles formed by mixtures of dimyristoylphospatidylcholine (DMPC)
ordi-O- tetradecylPC with dihexanoylphospatidylcholine or di-O-hexylPC
has been assessed by 1H and 15N NMR byWu et al.418 Thermodynamic and
structural behavior of equimolar mixtures of POPC and nonionic detergents
(tetraethylene glycol ethers Cn; n=8, 12, 16) has been elucidated by Pfeiﬀer
et al.419 using 2H and 31P NMR.
Model membrane (POPC/POPA/cholesterol) remodeling (interleaﬂet
diﬀusion of cholesterol) has been analyzed by Bruckner et al.420 using 13C
and 31P NMR. Hoeller et al.421 have characterized the commercial soybean
microemulsions by generating self-diﬀusion coeﬃcients of the individual
lipid components by 1H- and 31P NMR and DOSY experiment.
1D and 2D approaches have been used by Sasaki et al.422 to measure the
eﬀect of pH on sphingosine and sphingosine-1-phosphate aggregation.
Sivanandam et al.423 have elucidated the motion of PC in the membranes
with a focus on the interfacial region of the membrane using 13C ﬁeld
cycling NMR relaxation studies of sn-2-carbonyl-13C-PC.
Aucoin et al.424 have compared the 1HMAS NOESY experiment with the
1H MAS RFDR (radiofrequency driven dipolar decoupling) on DMPC
membranes to measure lipid motion and membrane – amino acids
interactions. NMR-based molecular ruler for determining the depth of
intercalants within the lipid bilayer have been developed Cohen et al.425,426
using 1H- and 13C NMR. Cohen et al.427 have also noticed the aggregate
formation in the intercalation of the long-chain fatty acids esters into
liposomes.
Solid-state 2H NMR has been used to elucidate various questions:
Brownholland et al.428 have investigated lipid organization - phase separ-
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Davis et al.429 have followed the coexistence of liquid-ordered and
liquid- disordered phases in ternary mixtures DOPC/DPPC-d62/CHO; Soni
et al.430 have analyzed the eﬀect of trans conﬁguration of unsaturated
fatty acid on their molecular organization in a phospholipid membrane;
Ora¨dd et al.431 have investigated the eﬀect of sterol on the lipid order and
bilayer rigidity (transverse relaxation study). The same method has been
used by Hsueh et al.432 to analyze the eﬀect of ergosterol on the physical
properties of the POPE bilayer; by Morrow et al.433 to follow the structural
behavior of binary systems composed of C16-ceramide or C16-ceramide-1-
phosphate with DPPC and by Juhasz et al.434 to quantitatively characterize
the coexisting phases in DOPC/DPPC/CHO mixtures using.
A new spin-labelled phospholipid analogue (doxyl-POPC) has been
proven by Bunge et al.,435 using solid-state 2H NMR, to be more appro-
priate to assess the versatile dynamics of POPC membranes than saturated
analogue used earlier.
Reviews
Wassall et al.436 have presented a review paper on the polyunsaturated
fatty acid – cholesterol interactions and domain formation in the mem-
branes; application of several NMR techniques has been described (e.g. 17O
NMR - the measurement of membrane permeability, 2H NMR - the
measurement of membrane order).
Lindblom et al.437 have reviewed the application of the pulse ﬁeld
gradient (pfg)-NMR method for measurements of translational diﬀusion of
molecules in macroscopically aligned lipid bilayers.
7.3 Lipid – drug interactions
Lipid vesicles (liposomes) have been proven to be a system of choice for the
delivery of pharmaceuticals to the cells. Design and optimalization of
the lipid vehicle requires the deep knowledge of the drug-liposome structure –
it has been studied by NMR in several papers mentioned below.
The eﬀect of curcumin on the model membrane (DMPC/DHPC bicelles)
structure has been studied by Barry et al.438 using solid-state 31P- and 14N
NMR. Changsan et al.439 have characterized the liposome (CHO/PC) sus-
pensions containing rifampicin by 2H and 31P NMR solid-state NMR.
Matsumori et al.440 have analyzed the interactions between amphotericin
B with ergosterol in deuterated ERG/POPC bilayers using 2H NMR. The
same group441 has investigated the amphotericin B-amphotericin B bimole-
cular interactions in sterol-containing POPCmembranes by 13C{19F}REDOR
experiment using 19F- and 13C-labelled amphotericin B.
Interactions of cisproﬂoxacin with DOPC/DPPC and DOPC/DPPG
membranes have been elucidated by Bensikaddour et al.442 using static 31P
NMR experiment. Xue et al.443 have used 1H NMR to elucidate the
hydrogen bonding between the gelator molecules (cholesteryl derivatives
containing phthaloyl, isophthaloyl and terephthaloyl moieties) and various
solvents.
Castro et al.444 have analyzed the interactions between anesthetics
(lidocaine and short chain alcohols) and DMPC membranes using 2H











364 | Nucl. Magn. Reson., 2011, 40, 344–390
antibiotics (gentamicin, tobramycin and amikacin) on the thermodynamic
properties of the DPPC membranes has been studied by Jia et al.445 using
31P NMR.
Al-Abdul-Wahid et al.446 have used a solution NMR (13C,1H T1-HSQC)
to measure the amphiphile immersion depth and orientation in membrane
model system (built of dodecylphosphocholine).
8 Glycolipids
The structure of various natural glycolipids has been analyzed using NMR.
1H NMR has been used by Xu et al.447 to determine the structure of fucosyl
glycosphingolipid of brine shrimp and by Tani et al.448 to establish the
structure of neogala-series glycosphingolipids of the fungus Hirsutella
rhossiliensis. Chechetkin et al.449 have determined the structure of pathogen-
inducible oxylipins (monogalactosyldiacylglycerol derivatives with esteriﬁed
divinyl ether residues) from ﬂax using 1H NMR and COSY spectra.
1D 1H- and 13C and 2D spectra have been used to determine the structure
of two cholestane glycosides of the rhizomes of Dioscorea septemloba by
Liu et al.450 and to evaluate the structure of the cell-surface glycolipid of
the spirochete Spirochaeta aurantia by Paul et al.451 The structure of
undecaprenyl phosphate-b-D-galactosamine, a sugar donor for biosynthesis
of Lipid A has been analyzed by Wang et al.452 using 1H, 13C, 31P NMR and
2D experiments.
9 Metabonomic studies
Development of NMR methodology and simultaneous rapid progress in
computer technology made the high-throughput studies on cellular meta-
bolom feasible. Elaboration of metabolomic approaches rapidly speeds up
the basic studies and provides the perspective for the development of the
new diagnostic tools. Numerous papers described below utilized such
approaches for speciﬁc clinical problems using either the model systems
(in vitro or in vivo) or the magnetic resonance imaging the tissue samples or
the entire body.
1H CPMG NMR spectra have been used by Wu et al.453 to elucidate
plasma metabolic proﬁles of functional dyspepsia patients, DF patients
treated with acupuncture and healthy control subjects using 1H CPMG
NMR spectra, and by Huo et al.454 to follow biochemical changes in the
serum of type 2 diabes mellitus patients treated with metformin
hydrochloride.
1H NMR has been applied to investigate the biochemical proﬁles of livers
of zebraﬁsh Danio rerio by Ong et al.455 to examine metabolism in the liver
and other tissues in Peroxisome Proliferator-Activated Receptor (PPAR)-
a–null mice and wild type controls during aging by Atherton et al.456 (tissue
extracts have been analyzed), to assess the eﬀect of dietary cholesterol in the
development of fatty liver disease (quantitative proﬁling of liver extracts
of mouse model) by Vinaixa et al.457
Dai et al.458 have analyzed the water depletion induced metabonomic
changes in Salvia miltiorrhiza (four sequential leaf extracts) by 1H NMR
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Proﬁling of human gut bacterial metabolism has been performed by de
Graaf et al.459 using metabolic labelling with [U-13C]glucose of the in vitro
model of human intestinal fermentation followed by 13C NMR and 2D
HSQC experiment.
Logan et al.460 have reported the characterization of the carbohydrate
modiﬁcations on Campylobacter jejuni ﬂagellin using metabolomics-
based approaches with application of 1D 1H and 13C NMR and 2D
experiments.
Klawitter et al.461 have elucidated the metabolic characteristics of leu-
kaemia cells – cell extracts were analyzed by 1H and 13C NMR.
Metabolomic analysis of the response of growing pigs to dietary
L-arginine supplementation has been performed on animal serum using
1H NMR, 1D NOESY, 2D COSY and TOCSY spectra were collected by
He et al.462
Allen et al.463 have analyzed the impact of light on soybean embryos
growth and metabolism by multiple labelling experiments and direct ﬂux
measurements employing 13C and 1H NMR.
Gue´nin et al.464 have analyzed the therapeutic eﬀect of methionine
deprivation on melanoma tumours by 1H HR MAS NMR metabolomic
analysis of pieces of intact melanoma tissues.
Raina et al.465 have followed the eﬃcacy of silibinin on prostate cancer
metabolism in mouse prostate model using quantitative 1H HR-NMR
metabolomics.
The metabolic proﬁle of human healthy and neoplastic colorectal tissues
has been obtained using ex vivo 1H HR MAS NMR by Righi et al.466
Li et al.467 have applied metabolic proﬁling to follow the Schistosoma
mansoni infection in mice using 1H MAS NMR of the tissues; 2D COSY
and TOCSY spectra were also acquired.
Duarte et al.468 have monitored the eﬀect of cell handling and storage on
cell integrity using 1H HRMAS NMR; CPMG and 2D TOCSY and HSQC
spectra.
Martin et al.469 have evaluated the eﬀect of diﬀerent dairy-based food
products on early atherogenesis in hiperlipidemic hamster using
plasma-based 1H NMR metabolomics, 1D CPMG and 2D COSY and
HSQC spectra.
1H NMR metabolomics of human plasma revealed strong sex dependent
proﬁle in 17-year-old individuals; 1D CPMG spectra were collected by
Bertram et al.470
Yao et al.471 have examined the eﬀect of phospholipids on the emulsion
stability recovered after aqueous extraction of soybean ﬂour and ﬂakes by
proﬁling and quantifying the phospholipids with 31P NMR.
Vauclare et al.472 have followed the metabolic rearrangement during
dark-induced carbohydrate starvation in soybean nodules using 13C- and
31P NMR.
Se´be´dio et al.473 have reviewed the recent advances in metabolomics tools
including application of NMR techniques. Lane et al.474 have described the
methodology and approaches, including NMR, to stable isotope tracing in
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10 New NMR methods
10.1 For sugars
Meier et al.475 have proposed 3D H2BC experiment, very useful for se-
quential assignment in the analysis of complex carbohydrates, which yields
simultaneously heteronuclear one- and two-bond and COSY correlations.
Vermillion and Price476 have shown that [carbonyl-13C]acetate labelling
of sugars allows to obtain their 2D and 3D diﬀusion ordered 13C spectra
(SIE-DOSY 13C NMR) in several minutes and hours, respectively.
Xia and Margulis477 have implemented J coupling calculations in their
Fast Sugar Structure Prediction Software which allows to investigate the
solution structure of sacharides.
a-Cyclodextrin has been shown by Rudzin´ska et al.478 to be a convenient
chemical shift reagent for determination of the enantiomeric composition of
a-hydroxyalkenephosphonic acids by 1D 31P NMR and 2D ROESY spectra.
10.2 For peptides/proteins
Soong et al.479 have implemented two-dimensional proton-evolved local-
ﬁeld (2D PELF) pulse sequences which can be used for the measurements of
a broad range of heteronuclear dipolar couplings, allowing a complete
mapping of protein dynamics in a lipid bilayer environment; magnetically
aligned bicelles containing cytochrome b5 served as an example.
New sensitivity enhanced HETCOR solid-state experiments (2D
SE-HETCOR, 3D HETCOR-SLF and 3D SE-PISEMAI-HETCOR) have
been presented by Gopinath et al.480 for oriented systems – the integral
membrane protein sarcolipin oriented in lipid bicelles served as an example.
Bertelsen et al.481 have presented a new method to obtain the local dy-
namics of membrane proteins by measuring 1H-15N dipole-dipole coupling,
15N anisotropic chemical shift and 2H quadrupole coupling for a single
residue; helix-tilt angle, wobbling and oscillatory rotation around the helix
were measured by them for peptaibol alamethicin oriented in DPMC. The
CF3-Ala labelling strategy combined with
19F SSNMR have been applied
by Maich et al.482 to study orientation and tilt of petaibols in membranes.
Shi et al.483 have proposed a reﬁnement protocol to determine the
structure, topology and depth of insertion of membrane proteins utilizing
both solution and solid-state NMR data. This hybrid approach has been
applied by this group to study the structure and topology of monomeric
phospholamban in lipid membrane.484
Fu et al.485 have reported the improvement in characterization of the
topology of 15N-labelled piscidin aligned in hydrated lipid bilayer by the use
of 1H-15N HETCOR NMR spectroscopy at 900 MHz ﬁeld.
Kouzayha et al.486 have presented a 31P and 15N MAOSS solid-
stateNMR strategy to study the eﬀects of inserting transmembrane peptides
in lipid bilayers.
Wang487 has applied 1Ha-13Ca crosspeak intensity plots from HSQC
spectra (called HSQC waves) of micelle-bound antimicrobial peptides for
indentifying key membrane–anchoring residues.
Holt et al.488 have introduced a new 2H SSNMR based strategy for the
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tilt angle of peptide in the presence of hydrophobic mismatch; for WALP23
peptide in DPMC membrane the value of 21o was determined.
Shenkarev et al.489 have tested lipid-protein nanodiscs in NMR structural
studies of membrane proteins.
Abdine et al.490 have used cell-free expression and solid-state NMR for
structural study of MscL, the selectively labelled membrane protein.
Franzmann et al.491 have described the background of the method based
on paramagnetic relaxation enhancement for determining at atomic reso-
lution the orientation and insertion depths of peptides in micelles.
McDermott492 has reviewed application of MAS SSNMR technique to
study the structure and dynamics of membrane proteins of moderate size in
lipid bilayers.
Van Horn et al.493 have discussed the impact of window functions on
NMR based paramagnetic relaxation enhancement measurements in
membrane proteins.
Water-edited solid-state NMR spectroscopy that allows probing protein
conformation in a lipid bilayer has been described by Ader et al.494
Segmental isotope labelling of glycoproteins has been reviewed by
Skrisovska et al.495 in relation to NMR investigations.
The 14N-PISEMA experiment which correlates 14N quadrupolar coupling
and 1H-14N dipolar coupling has been proposed by Qian et al.496 as a
sensitive probe for peptide orientation in planar membranes.
10.3 For lipids
Espindola et al.497 have used a selective homonuclear decoupling of multiple
protons simultaneously that allows a fast and reliable determination of
speciﬁc coupling values from complex spectra and permits determination of
relative conﬁguration of small molecules.
Petzold et al.498 have established a semiconstant time 2D 1H-31P COSY
experiment that allows identiﬁcation and quantiﬁcation of phospholipids in
complex mixtures; phospholipids of Helicobacter pylori have been analyzed
as an example.
Lundbom et al.499 have elucidated the detailed echo time behaviour of
the selected fatty acid and explored the in vivo feasibility of long TE
spectroscopy in characterizing human adipose tissue using 1H NMR with a
PRESS sequence.
Roberts et al.500 have used the high resolution 31P ﬁeld cycling NMR to
measure the spin-lattice relaxation rate to explore the energy barriers
associated with phospholipid motion in unilamellar vesicles.
Ciesielski et al.501 have proposed the use of Lee-Goldburg decoupling in
high resolution natural abundance 13C CP-MAS NMR to investigate
changes in molecular and segmental dynamics of membrane lipids.
11 Data bases for sugars
Based on NMR parameters SOACS index, a new type of query of glycan
sequences in GlycomeDB, several available uniﬁed web databases has been
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12 Miscellaneous
Long and Yang503 using 15N relaxation measurements have reported on
MES buﬀer interference with functionally relevant human liver fatty acid
binding protein (hLFABP) dynamics (ms – ms).
Nine new cannabinoids have been isolated and their structures solved by
Radwan et al.504 Endocannabinoid binding to the cannabinoid receptors
has been reviewed by Reggio;505 this includes NMR studies. The analysis of
the structure of the C-terminus of the human cannabinoid receptor in the
presence of DPC micelles carried out by Ahn et al.506 has revealed two
amphiphathic helices. Tiburu et al.507 have reported membrane dependent
structure of a human cannabinoid receptor-1 helix domain.
Quantitative characterisation of insertion depth and relative orientation
of ganglioside GM1 in DPMC/CHAPSO bilayer has been done by
DeMarco et al.508 utilizing paramagnetic relaxation data. The interactions
between micelles of ganglioside lyso-GM1and amyloid b have been
characterised with various NMR techniques by Yagi-Utsumi et al.509
The interactions of the C2B domain of Syt1, p40 synaptotagmin with
SUV in the presence of Cu2þ cations have been characterised by Kathir
et al.510 using 1H-15N HSQC spectra.
15N{31P}REDOR experiments have been used by Garimella et al.511 to
measure the distances between D-alanine amine groups of teichoic acid and
phosphate groups within cell wall fragments of Bacillus subtilis in the
presence and absence of Mg2þ ions.
Ogino et al.512 have introduced 15N labelled Tb4 into living mammalian
cells by reversible membrane permeabilization and measured in-cell NMR
spectra of this protein.
Kielec et al.513 have employed reverse micelle encapsulation to solubilise
the protein in a low-viscosity solvent. This approach allows using of
standard triple-resonance NMR methods in structural studies. The
approach has been applied by the authors to a 54 kDa construct of the
heterodimeric potassium channel KcsA in CTAB/HDAB micelles.
A cross-polarization 31P NMR has been applied by Fotakis et al.514 for
studying conformational changes and dynamics in DPPC multilamellar
bilayers under inﬂuence of antihypertensive AT1 antagonist, Losartan.
Bolaamphiphile-class surfactants composed of two maltoside headgroups
connected by long saturated alkyl chain have been tested using NMR















































SUV small unilamellar vesicles
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